Many asset allocators are waiting for bond yields to hit 6% before they flip the switch from equities to fixed income, but a ...

The nation's largest bank reported earnings that fell short of Wall Street's expectations after the company saw a slowdown in markets and investment-banking activity. JPMorgan reported a profit of $15 ...

Shares of Canada's Enerflex climbed premarket after the company was contracted to design, engineer and build over one gigawatt of low-emission behind-the-meter natural gas-fired power-generation units ...

Cineplex's box office draw in September capped a record-setting third quarter thanks to Spider-Man: Brand New Day and The Odyssey. The Canadian movie theater and entertainment company said September's ...

A fatal accident on a Six Flags Entertainment roller coaster sent shares of the amusement-park operator near the lowest level ...

The four-year bull market in stocks is riding high because of the AI boom. But it’s also increasing the cost of money.

The drug, a biosimilar--or copycat version--of Keytruda, was developed by Formycon and licensed to Zydus, which holds exclusive commercialization rights for the U.S. and Canada. The FDA filing ...

BioNTech said its cancer immunotherapy BNT113 didn't meet the first dual primary endpoint of progression-free survival in a recent phase 2/3 trial.

CSG said it bought a 9.5% stake in MDA worth around C$620 million (US$434.1 million). The investment positions CSG as MDA's largest shareholder and could see the companies co-inve ...

Hitachi Ltd. and major Japanese industrial robot manufacturer Fanuc Corp. have launched a partnership in the field of physical AI, the companies have announced.

A commercial-launch bottleneck has spurred an unprecedented wave of investment in space infrastructure and applications ...

After an eventful summer, U.S. stocks appear to have hit a pocket of calm. Over the past few sessions, trading volume has ...